| Corporate Name | SETOLAS Holdings, Inc. | ||||
|---|---|---|---|---|---|
| Establishment | August 2022 | ||||
| Paid up Capital | JPY 144,000,000. | ||||
| Representative Director Chairman | Shunji Oishi | ||||
| CEO | Koji Kinoshita | ||||
| Director | Yo Abe Katsuya Ueda Mitsunori Kado Masahiro Tai Teruaki Kakimoto Nobuhiro Kagoike |
||||
| Number of Employees | 130 (as of Oct. 2022) | ||||
| Products | Group Management and Consulting Business | ||||
| Offices | [Head Office] 1F/2F Anabuki Togiya-machi Bldg. 8-1 Togiya-machi, Takamatsu, Kagawa, Japan 760-0026 [Google maps] TEL +81-87-826-6610 FAX +81-87-826-6616 [SETOLAS Lab] Sakaide R&D center, Agribio R&D center, Magmitt pharmaceutical R&D center, Innovation center(to be constructed) |
||||
| Group Companies | SETOLAS Holdings Group | ||||
| Banks |
|
||||
| Sales records | 3 companies consolidated(SETOLAS Holdings, Kyowa Chemical Industry, Magmitt Pharmaceutical) Sales in JPY millions
|
